Connect with us

Healthcare

Got Neuropathy, Try a Cannabis Inhaler For the Best Pain Relief Says New Israeli Study

Published

on

The best relief for neuropathy patients was aerosolized cannabis says new medical study?

Israeli Study Finds That Aerosolized Cannabis Is Beneficial For Neuropathy Patients

Neuropathy, also known as nerve damage, can occur from several conditions such as diabetes, cancer, and HIV. It refers to a group of conditions all associated with damaged peripheral nerves and the corresponding symptoms of this issue.

The symptoms of neuropathy can vary depending on its cause, though they generally include a permanent or temporary numbness, high sensitivity to touch, prickling or tingling sensations, paralysis, muscle weakness, impairment to sexual function, and many others. Neuropathy may be treatable depending on how severe it is, though treatments are focused on helping nerves regenerate or recover. Depending on the case, neuropathy may be reversible but other times it isn’t, and it can be notoriously difficult and painful to treat. Patients are often left struggling with chronic pain and uncomfortable tingling.

However, finding effective treatment is critical because this condition robs people of living a normal life.

How Cannabis Can Help

There is increasing evidence that cannabis in various forms can be successful in greatly reducing the symptoms of neuropathy. The latest study has been conducted by Israeli researchers in Haifa, who sought out to assess how aerosolized cannabis delivered through a novel selective dose inhaler worked among patients with chronic pain and neuropathy. The patients took an average of 1.5 mg delta 9 THC for several months.

The researchers found that this treatment was beneficial in reducing pain while also improving quality of life. “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-ups in a larger population is warranted to corroborate our findings,” the authors concluded.

Syqe Medical is an Israeli medical company that is responsible for developing the first selective-dose pharmaceutical-grade inhaler for plant medicine in the world.

Another recent study which was published in the Annals of Internal Medicine journal investigated the efficacy of cannabis-related products for chronic pain. Researchers from the Oregon Health and Science University used FDA-approved synthetic cannabis products containing 100% THC: dronabinol and nabilone. They also tested a product called nabiximols, which is a sublingual spray containing equal ratios of THC and CBD, which has had some success in treating neuropathic pain, though it isn’t available in the United States yet.

In another study from 2018, published in the American Journal of Neurology, researchers focused on radicular pain, a form of nerve pain that affects the spine and the legs. They also analyzed the impact of THC on radicular pain on a cohort of 15 men suffering from chronic radicular nerve pain. Women were not included in the study since pain sensitivity in females fluctuates around the time of their menstruation. All men reported medium to high pain levels for more than 6 months.

They were first given 15mg of THC oil on the first visit, which was taken sublingually while 6 were administered with placebo oil. After a week, they returned for a second visit then those who were given placebo were then given THC, and vice versa. The researchers found that THC was effective in reducing pain when compared with the placebo. Pain levels were rated at 53 on average before taking THC which was reduced to an average of 35 after THC, while those in the placebo rated it at 43.

“Pain is a complex experience that involves both the senses and emotions,” explains study’s author Haggai Sharon, MD, of the Tel Aviv Medical Center’s Sagol Brain Institute. “Our study results link pain relief from THC with a reduction in the connections between areas of the brain otherwise heavily connected, suggesting that THC may alleviate pain by disrupting signals between these pain processing pathways.”

“Interestingly, our results also show that the more connected the areas of the brain that process emotion and sensory prior to treatment, the greater the pain relief experienced when taking THC,” Sharon explains. “Larger studies are needed to confirm our findings.”

Cannabidiol (CBD) may also be beneficial for neuropathy. A 2021 study conducted by Pure Green Pharmaceuticals Inc. analyzed the effect of water-soluble CBD sublingual tablets among diabetic patients who had moderate to severe neuropathic pain. These 54 patients suffered from painful peripheral neuropathy on their feet, and they were randomly given either the Pure Green tablets with 20mg of CBD, or a placebo, which they were to take daily for 28 days.

They found that the patients who were given the CBD tablets reported significant reductions in pain levels, compared to the pain group. Additionally, those given CBD also reported improvements in quality of life as well as reductions in anxiety and improvements in sleep quality.

“Achieving clinical and statistical pain relief for these patients in just a few weeks is very gratifying and frankly unexpected. Interestingly, the results of this placebo-controlled trial mirrored those of Pure Green Pharmaceuticals’ open-label pDPN trial where both studies revealed a significant drop in pain scores by approximately 50 percent. Patient safety always comes first and was our primary marker. There were no adverse events in either clinical trial to patients on treatment medication,” explained Dr. Debra Kimless, Pure Green’s Chief Medical Officer and a Board-Certified anesthesiologist.

“A collaborative drug development meeting with the FDA set us on this path and we look forward to returning to FDA and share this data. FDA is keen to relieve patients suffering in this very large patient population, especially since COVID-19 appears to have increased the number of diabetic patients,” added Stephen Goldner, Pure Green Pharmaceuticals CEO, and an FDA expert.

Conclusion

With these promising results, patients with neuropathy are encouraged to speak to their doctors on the possibility of adding cannabis products to their treatment plans.

Source: https://cannabis.net/blog/medical/got-neuropathy-try-a-cannabis-inhaler-for-the-best-pain-relief-says-new-israeli-study

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Economic Fraud

Fugitive Medicare Fraud Suspect Returned to US After Arrest in Türkiye

Published

on

By

U.S. federal authorities have secured the return of a fugitive suspect accused of involvement in a massive Medicare fraud operation, following his arrest in Türkiye. The extradition marks a significant development in a major healthcare fraud investigation that allegedly cost the American healthcare system billions of dollars.

The suspect, Ibrahim Khaldoon Hilmi, is now in federal custody after spending more than a year outside the United States. Prosecutors are expected to move forward with criminal proceedings as investigators continue to examine what authorities describe as a sophisticated fraud network targeting public healthcare funds.

International Manhunt Ends with Arrest in Türkiye

According to federal investigators, Hilmi left the United States in May 2025 while authorities were building their case. Law enforcement agencies later tracked his location to Türkiye, where cooperation between U.S. and Turkish officials led to his detention.

Following the completion of legal and diplomatic procedures, the suspect was transferred to American custody. Officials described the operation as a successful example of international law enforcement collaboration in pursuing suspects accused of large-scale financial crimes.

A specialized FBI team reportedly traveled to Türkiye to coordinate the transfer and ensure the extradition process was completed smoothly.

Alleged Scheme Targeted Medicare Reimbursement System

Investigators allege that Hilmi played a central role in a fraudulent operation that exploited the Medicare reimbursement system through false claims and improper billing practices.

Authorities estimate that the alleged scheme involved financial losses equivalent to approximately ₹31,700 crore, making it one of the most significant healthcare fraud investigations in recent years.

While the allegations have yet to be tested in court, investigators believe the operation relied on complex financial transactions and coordinated activities designed to extract funds from a government healthcare program serving millions of beneficiaries.

Federal Agencies Expand Investigation

The case extends beyond a single suspect. Federal authorities are examining the potential involvement of additional individuals, businesses, and organizations believed to be connected to the alleged fraud network.

Investigators are reviewing banking records, financial transactions, corporate structures, and digital evidence to determine the full scope of the operation and identify any additional participants.

Officials indicated that tracing the movement of funds and uncovering potential links between entities remains a key focus of the ongoing investigation.

Healthcare Fraud Remains a Major Concern

Government agencies continue to treat Medicare fraud as a serious threat because it impacts taxpayer-funded healthcare resources intended for legitimate medical services.

Authorities argue that fraudulent claims can divert critical funding, increase administrative costs, and place additional pressure on public healthcare programs. As healthcare systems become increasingly digitized, fraud schemes have also become more sophisticated and difficult to detect.

Financial crime specialists note that modern healthcare fraud investigations often involve shell companies, layered transactions, and cross-border financial networks that require extensive forensic analysis.

Growing Importance of Global Law Enforcement Cooperation

The successful return of Hilmi highlights the increasing role of international cooperation in combating financial crime. Law enforcement agencies worldwide are relying more heavily on cross-border partnerships to locate and apprehend suspects who attempt to evade prosecution by relocating overseas.

Officials say such collaborations are essential as financial crimes become increasingly global in nature, involving multiple jurisdictions and complex international money flows.

Legal Proceedings Ahead

The U.S. Department of Justice is expected to present evidence against the suspect as court proceedings move forward. Prosecutors will seek to establish the extent of the alleged fraud and determine accountability among those involved.

The outcome of the case could influence future enforcement efforts aimed at protecting public healthcare programs and strengthening safeguards against large-scale financial misconduct.

For federal authorities, the extradition of Ibrahim Khaldoon Hilmi represents a major step in an ongoing campaign to crack down on healthcare fraud and recover public funds allegedly lost through criminal schemes.

Continue Reading

Cyber Crime

Telangana Doctors Lose Nearly ₹30 Crore to Cyber Fraud Since September 2024

Published

on

By

Cybercriminals have defrauded doctors across Telangana of nearly ₹30 crore since September 2024, prompting authorities to strengthen awareness campaigns and cybersecurity education within the healthcare sector.

The alarming figures were revealed during a cyber awareness programme organized by the Telangana Cyber Security Bureau (TGCSB) in Hyderabad. Senior officials warned that healthcare professionals are increasingly becoming targets of sophisticated online scams despite their educational and professional backgrounds.

Healthcare Professionals Under Growing Cyber Threat

Addressing representatives from various medical associations, TGCSB Director Shikha Goel highlighted the rising number of cybercrime incidents involving doctors and healthcare workers. She emphasized that cybercriminals are exploiting digital platforms to target individuals across all professions, including highly qualified medical practitioners.

Officials stressed that vigilance, awareness, and prompt reporting remain the strongest defenses against cyber fraud. The event focused on strengthening cooperation between law enforcement agencies and the medical fraternity to improve preparedness against evolving cyber threats.

More than 70 office-bearers from medical organizations across Telangana attended the session, including presidents, secretaries, treasurers, and senior representatives.

Investment Scams Responsible for Major Financial Losses

According to TGCSB data, at least 735 doctors have reported cybercrime-related incidents since September 2024, with total losses reaching approximately ₹29.88 crore.

Business and investment fraud emerged as the most damaging category, accounting for losses of ₹22.39 crore involving 127 victims. Investigators noted that fraudsters often lure professionals with promises of high returns, fake investment opportunities, and deceptive business schemes.

Authorities also reported a wide range of other cyber offences affecting doctors, including digital arrest scams, identity theft, impersonation fraud, fake advertisements, job-related scams, insurance fraud, cryptocurrency fraud, UPI-related cheating, matrimonial scams, and sextortion cases.

Authorities Stress Importance of Rapid Reporting

The Telangana Cyber Security Bureau urged victims to report cybercrime incidents immediately, especially during the critical “golden hour” after a fraudulent transaction occurs.

Officials explained that timely complaints through the national cybercrime helpline 1930 and the official cybercrime reporting portal can significantly improve the chances of freezing suspicious transactions and recovering stolen funds.

The bureau further warned that cybercriminals are employing increasingly advanced techniques to deceive victims, making awareness and quick action more important than ever.

Medical Associations Join Awareness Drive

Representatives from associations of paediatricians, cardiologists, dentists, orthopaedic surgeons, gynaecologists, and hospital administrators participated in the discussions. The groups pledged to work closely with authorities to spread cybersecurity awareness through hospitals, clinics, medical conferences, and professional training programmes.

Officials believe that expanding cyber awareness among healthcare professionals will play a key role in reducing financial fraud and strengthening digital security across the state’s medical community.

As cyber threats continue to evolve, law enforcement agencies are encouraging doctors and other professionals to remain cautious when responding to investment offers, unknown communications, and requests for sensitive financial information online.

Continue Reading

Education News

AIIMS Gorakhpur Reservation Controversy: FIR Alleges Fake OBC Certificate Used Despite ₹80 Lakh Income

Published

on

By

A major controversy has emerged at AIIMS Gorakhpur after allegations surfaced that reservation benefits were misused to secure a postgraduate medical seat. A criminal case has been registered against former AIIMS Gorakhpur Executive Director Dr. G.K. Pal and his son, Dr. Oro Prakash Pal, over the alleged use of a forged Other Backward Class (OBC) Non-Creamy Layer certificate for admission to an MD course.

The case has triggered widespread debate within medical and administrative circles, raising serious questions about transparency and oversight in admissions to premier medical institutions.

FIR Filed on Court’s Direction

The First Information Report (FIR) was registered at the AIIMS police station following directions from Chief Judicial Magistrate Tvishi Srivastava. According to the complaint, the alleged offence took place on August 30, 2024, when forged documents were purportedly used to obtain an MD seat under the OBC reservation quota.

Sources indicate that the matter was subsequently brought to the attention of the Union Ministry of Health, prompting internal reviews and administrative action.

Alleged Income Far Above Eligibility Threshold

Central to the allegations is the claim that Dr. G.K. Pal and his wife Parvati Pal have a combined annual income exceeding ₹80 lakh. Under existing reservation rules, families with such income levels are not eligible for OBC Non-Creamy Layer benefits.

Following the emergence of the controversy, Dr. Pal was first removed from his position at AIIMS Gorakhpur and later relieved of responsibilities at AIIMS Patna. He is currently posted at JIPMER Puducherry. With the registration of the FIR, officials suggest that further legal and departmental action may follow, depending on the outcome of the investigation.

Complaint Highlights Systemic Concerns

The complaint was filed by Ashutosh Kumar Mishra, a resident of Divyanagar in the Cantonment area. He alleged that the events related to the case occurred between January and September 2024. The complainant argued that misuse of reservation provisions by individuals in senior positions undermines the integrity of public institutions and erodes trust in the medical education system.

The case has reignited concerns over whether verification mechanisms for reservation certificates are robust enough, particularly in high-stakes admissions.

Impact on Medical Community

The allegations have sent shockwaves through the medical fraternity. Experts believe that if the claims are substantiated, the case could prompt a broader review of admission procedures and lead to stricter scrutiny of category certificates across institutions like AIIMS.

Authorities have stated that all relevant documents will be carefully examined before taking further steps. The outcome of the investigation is expected to have far-reaching implications for accountability and compliance in medical admissions.

Questions Await Answers

As the probe continues, several key issues remain unresolved: whether reservation norms were deliberately violated, how verification processes failed, and whether similar cases may surface in the future. For now, the focus remains on the investigation and its potential consequences.

Continue Reading

Trending

Copyright © 2022 420 Reports Marijuana News & Information Website | Reefer News | Cannabis News